ALGOTHERAPEUTIX is a startup based in France, most recent round Series B, 2 tracked investors.
Based in France, ALGOTHERAPEUTIX is a startup. Its most recent tracked round is Series B. Brouky records 2 investors associated with the company.
AlgoTherapeutix is a clinical-stage biotechnology company focused on developing non-opioid therapies for peripheral neuropathic pain. Its lead candidate, ATX01, is a topical formulation of amitriptyline designed to inhibit pain signaling by targeting peripheral sensory nerve fibers, specifically for chemotherapy-induced peripheral neuropathy and erythromelalgia.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.